Key result
Drug-eluting stents provide sustained inhibition of neointimal proliferation following percutaneous coronary intervention.
Design
Review
Authors
Loading...
Supports second-generation DES in PCI; extends prior reviews while leaving comparative trials open.
Provides an overview of second-generation drug-eluting coronary stents in percutaneous coronary intervention.
Lange et al. (2010) conducted a review in Coronary artery disease requiring percutaneous coronary intervention. Second-Generation Drug-Eluting Coronary Stents was evaluated. Drug-eluting stents provide sustained inhibition of neointimal proliferation following percutaneous coronary intervention.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: